Denosumab biosimilar by Lupin for Post Menopausal Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Lupin and currently in Phase III for Post Menopausal Osteoporosis.

Is It Time to Add Universal CMV Screening for Newborns?

BOSTON — The time for universal congenital cytomegalovirus (cCMV) screening may well be here, researchers said. In a study of nearly 24,000 newborns across six

October 14, 2023

Windtree and Lee’s sign licence agreement for heart failure therapy

Share this article Istaroxime is intended to treat patients with acute heart failure and cardiogenic shock. Credit: Ahmet Misirligul/Shutterstock.com. Windtree Therapeutics and Lee’s Pharmaceutical have

January 18, 2024

Pharmalittle: We’re reading about FDA plans to ban a cold med; Eisai Alzheimer’s drug sales, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.